University Medicine Rostock
Desconocido
PlasmACT: Plasma Medicine against Actinic Keratosis
UNIVERSITATSMEDIZIN ROSTOCK
participó en un
HORIZON EUROPE:
HORIZON-MSCA-2022-DN-01
The quality of human (and veterinary) health care systems substantially depends on key innovations. Often, these were driven by the field of...
2023-05-11 - 2027-12-31 | Financiado
2023-05-11 - 2027-12-31 | Financiado
CombiDiag: Peripheral Biomarker Based Combinatorial Early Diagnostics for Dementia
UNIVERSITATSMEDIZIN ROSTOCK
tramitó un
HORIZON EUROPE:
HORIZON-MSCA-2021-DN-01
CombiDiag DN aims to develop an AI-data-driven peripheral biomarker based combinatorial diagnostic protocol for early stages of Alzheimers d...
2023-02-01 - 2027-01-31 | Financiado
2023-02-01 - 2027-01-31 | Financiado
ALIVER: Development of DIALIVE a novel Liver Dialysis Device for the treatment of patients with Acute on Ch...
UNIVERSITATSMEDIZIN ROSTOCK
participó en un
H2020:
H2020-SC1-2016-2017
Liver disease incidence is increasing and about 170K patients die from liver failure each year in Europe. In liver failure, the accumulation...
2016-12-01 - 2021-01-31 | Financiado
2016-12-01 - 2021-01-31 | Financiado
BBDiag: Blood Biomarker based Diagnostic Tools for Early Stage Alzheimer s Disease
UNIVERSITATSMEDIZIN ROSTOCK
participó en un
H2020:
H2020-MSCA-ITN-2016
Alzheimer’s disease (AD) affects more than 7 million people in Europe and this figure is expected to double every 20 years. Despite intensiv...
2016-09-12 - 2021-12-31 | Financiado
2016-09-12 - 2021-12-31 | Financiado
CoCA: Comorbid Conditions of Attention deficit hyperactivity disorder
UNIVERSITATSMEDIZIN ROSTOCK
participó en un
H2020:
H2020-PHC-2014-2015
Understanding mechanisms underlying comorbid disorders poses a challenge for developing precision medicine tools. Psychiatric disorders are...
2015-12-16 - 2021-06-30 | Financiado
2015-12-16 - 2021-06-30 | Financiado
IMPACT: Ion Molecule Processes for Analytical Chemical Technologies
UNIVERSITATSMEDIZIN ROSTOCK
participó en un
H2020:
H2020-MSCA-ITN-2015
Soft chemical-ionization mass-spectrometry (SCIMS) is an exquisitely sensitive analytical technique with applications to health, the environ...
2015-08-10 - 2019-12-31 | Financiado
2015-08-10 - 2019-12-31 | Financiado
Ageing with elegans: Validating C. elegans healthspan model for better understanding factors causing health and disease...
UNIVERSITATSMEDIZIN ROSTOCK
participó en un
H2020:
H2020-PHC-2014-2015
Healthspan (the life period when one is generally healthy and free from serious disease) depends on nature (genetic make-up) and nurture (en...
2015-04-09 - 2020-10-31 | Financiado
2015-04-09 - 2020-10-31 | Financiado
HEARTEN: A co operative mHEALTH environment targeting adherence and management of patients suffering from Hea...
UNIVERSITATSMEDIZIN ROSTOCK
participó en un
H2020:
H2020-PHC-2014-2015
HEARTEN will design, develop and validate an ICT co-operative environment that will enable the HF patients to achieve sustainable behavior c...
2014-12-05 - 2018-03-31 | Financiado
2014-12-05 - 2018-03-31 | Financiado
PRIMA-EDS: Polypharmacy in chronic diseases Reduction of Inappropriate Medication and Adverse drug events in e...
UNIVERSITATSMEDIZIN ROSTOCK
participó en un
FP7:
Background: Treatment of chronic diseases in the elderly with polypharmacy poses a threat to patient outcome and involves extensive costs. L...
Financiado
Financiado
SMART-HIP: Sensor Based Detection of Implant Loosening in Total Hip Replacements
UNIVERSITATSMEDIZIN ROSTOCK
participó en un
FP7:
Ageing, sedentary behaviour,and obesity are predictors of osteoarthritis, and the combination of arthritis and obesity causes an undue stres...
Financiado
Financiado
* No se disponen de datos de la empresa actual.